Venetia Tragkola

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

High Performance Liquid Chromatography

Pluripotent Stem Cells

Top Venues

Plants (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Sotiris Kyriakou, Venetia Tragkola, Ioannis Paraskevaidis, Michael Plioukas, Dimitrios T Trafalis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
Chemical Characterization and Biological Evaluation of Epilobium parviflorum Extracts in an In Vitro Model of Human Malignant Melanoma. Plants (Basel, Switzerland) 12 (8) (2023)
Sotiris Kyriakou, Venetia Tragkola, Ioannis Paraskevaidis, Michael Plioukas, Dimitrios T Trafalis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
Chemical Characterization and Biological Evaluation of Epilobium parviflorum Extracts in an In Vitro Model of Human Malignant Melanoma. Plants (Basel, Switzerland) 12 (8) (2023)
Sotiris Kyriakou, Venetia Tragkola, Ioannis Paraskevaidis, Michael Plioukas, Dimitrios T Trafalis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
Chemical Characterization and Biological Evaluation of Epilobium parviflorum Extracts in an In Vitro Model of Human Malignant Melanoma. Plants (Basel, Switzerland) 12 (8) (2023)
Sotiris Kyriakou, Venetia Tragkola, Ioannis Paraskevaidis, Michael Plioukas, Dimitrios T Trafalis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
Chemical Characterization and Biological Evaluation of Epilobium parviflorum Extracts in an In Vitro Model of Human Malignant Melanoma. Plants (Basel, Switzerland) 12 (8) (2023)
Sotiris Kyriakou, Venetia Tragkola, Heba Alghol, Ioannis Anestopoulos, Tom Amery, Kyle Stewart, Paul G Winyard, Dimitrios T Trafalis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis
Evaluation of Bioactive Properties of Lipophilic Fractions of Edible and Non-Edible Parts of Nasturtium officinale (Watercress) in a Model of Human Malignant Melanoma Cells. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)